Science is underserved as women underrepresented in oncology drug trials

Sex differences appear to persist in recruitment to clinical trials for new therapeutics across common solid cancer types. An analysis of lung, colon, thyroid, melanoma, kidney, and pancreas cancer drug trials between 2000 and 2020 found women comprised 40% of the participants overall. “We observed significant differences between the enrollment of sexes across all trial ...

Already a member?

Login to keep reading.

© 2022 the limbic